Gunturu, K.S. et al. 2010. Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer. JOP. Journal of the Pancreas. 11, 5 (Sep. 2010), 484–485. DOI:https://doi.org/10.6092/1590-8577/3443.